ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 155 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -100.0% | 76,300 | +63.0% | 0.00% | -100.0% |
| Q3 2022 | $15,000 | +7.1% | 46,800 | -43.0% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | +250.0% | 82,100 | -19.0% | 0.00% | – |
| Q1 2022 | $4,000 | +33.3% | 101,300 | +151.4% | 0.00% | – |
| Q4 2021 | $3,000 | -76.9% | 40,300 | -26.3% | 0.00% | – |
| Q3 2021 | $13,000 | +160.0% | 54,700 | +147.5% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 22,100 | -70.2% | 0.00% | – |
| Q4 2020 | $5,000 | -97.8% | 74,200 | +44.5% | 0.00% | -100.0% |
| Q2 2019 | $224,000 | +833.3% | 51,342 | +99.0% | 0.02% | +800.0% |
| Q1 2019 | $24,000 | +140.0% | 25,800 | +8.9% | 0.00% | +100.0% |
| Q4 2016 | $10,000 | +900.0% | 23,700 | -21.0% | 0.00% | – |
| Q3 2014 | $1,000 | -96.6% | 30,000 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $29,000 | -23.7% | 30,000 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $38,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
| MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
| MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
| CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
| Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
| Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
| MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
| Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
| ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
| Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |